EBV-positive diffuse large B-cell lymphoma with central nervous system involvement in Anti-Mi-2-positive dermatomyositis.

Kachi S; Nakashima R; Ito H; Fujimoto R; Sasai T; Shirakashi M; Hiwa R; Tsuji H; Akizuki S; Onishi A; Yoshifuji H; Morinobu A

doi:10.1093/rap/rkag041

← 뒤로

EBV-positive diffuse large B-cell lymphoma with central nervous system involvement in Anti-Mi-2-positive dermatomyositis.

0/5 보강

Rheumatology advances in practice 2026 Vol.10(2) p. rkag041 OA

Kachi S, Nakashima R, Ito H, Fujimoto R, Sasai T, Shirakashi M

📖 무료 전문 🟢 PMC 전문 PMC13075938 🔓 OA PDF unpaywall · cc-by

PubMed ↗ DOI ↗ BibTeX ↓ RIS ↓

이 논문을 인용하기

↓ .bib ↓ .ris

APA Kachi S, Nakashima R, et al. (2026). EBV-positive diffuse large B-cell lymphoma with central nervous system involvement in Anti-Mi-2-positive dermatomyositis.. Rheumatology advances in practice, 10(2), rkag041. https://doi.org/10.1093/rap/rkag041

MLA Kachi S, et al.. "EBV-positive diffuse large B-cell lymphoma with central nervous system involvement in Anti-Mi-2-positive dermatomyositis.." Rheumatology advances in practice, vol. 10, no. 2, 2026, pp. rkag041.

PMID 41983235 ↗

DOI 10.1093/rap/rkag041

같은 제1저자의 인용 많은 논문 (2)

Five-year survival of patients with non-small cell lung cancer treated with alkalization therapy.
Translational oncology 2026
Immune checkpoint inhibitor-induced myocarditis and multiple adverse events with pre-existing rheumatoid arthritis: a case report and literature review.
Immunological medicine 2025